Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas

Cancer

Volumn 79, Issue 12, 1997, Pages 2371-2379

  Collin, Françoise ^a   Chassevent, Agnès ^b   Bonichon, Françoise ^c   Bertrand, Gérard ^b   Terrier, Philippe ^d   Coindre, Jean Michel ^c  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b CENTRE PAUL PAPIN   (France)

^c INSTITUT BERGONIÉ   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Flow cytometry; Ploidy; Prognosis; Proportional hazards model; Sarcoma; Soft tissue neoplasm

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; DNA CONTENT; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SARCOMA; SOFT TISSUE TUMOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANEUPLOIDY; DIPLOIDY; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; S PHASE; SARCOMA;

EID: 0031005764     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970615)79:12<2371::AID-CNCR11>3.0.CO;2-O     Document Type: Article

References (43)

1. Gaynor JJ, Tan CC, Casper ES, Collin CF, Friedrich C, Shiu M, et al. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol 1992;10:1317-29.
2. Mandard AM, Petiot JF, Marnay J, Mandard JC, Chasle J, De Ranieri E. Prognostic factors in soft tissue sarcomas: a multivariate analysis of 109 cases. Cancer 1989;63:1437-51.
3. Trojani M, Contesso G, Coindre JM, Rouëssé J, Bui NB, De Mascarel A, et al. Soft tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37-42.
4. Coindre JM, Trojani M, Contesso G, David M, Rouëssé J, Bui NB, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986;58:306-9.
5. Coindre JM, Terrier P, Bui BN, Bonichon F, Collin F, Le Doussal V, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the Franch Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996;14:869-77.
6. Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas: results of a clinico-histopathologic correlation in a series of 163 cases. Cancer 1984;53:530-41.
7. Merkel DE, McGuire WL. Ploidy, proferative activity and prognosis: DNA flow cytometry of solid tumors. Cancer 1990;65:1194-205.
8. Vindelov LL, Christensen IJ, Nissen NI. A detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7.
9. Shankey T, Rabinovitch P, Bagwell B, Bauer K, Duque R, Hedley D, et al. Guidelines for implementation of clinical cytometry. Cytometry 1993;14:472-7.
10. Weiss SW. Histological typing of soft tissue tumours. 2nd edition. Geneva: World Health Organization, 1994.
11. Enzinger FM, Weiss SW. Soft tissue tumors. 3rd edition. St Louis: CV Mosby, 1994.
12. Kreicsberg A, Tribukait B, Willems J, Bauer HCF. DNA flow analysis of soft tissue tumors. Cancer 1987;59:128-33.
13. Stenfert Kroëse MC, Rutgers DH, Wils IS, Van Unnik JAM, Roholl PJM. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 1990;65:1782-8.
14. Alho A, Skjeldal S, Melvik JE, Pettersen EO, Larsen TE. The clinical importance of DNA synthesis and aneuploidy in bone and soft tissue tumours. Anticancer Res 1993;13:2383-8.
15. Alho A, Skjeldal S, Pettersen EO, Melvik JE, Larsen TE. Aneuploidy in benign tumors and nonneoplastic lesions of musculoskeletal tissues. Cancer 1994;73:1200-5.
16. Matsuno T, Gebhardt MC, Schiller AL, Rosenberg AE, Mankin HJ. The use of flow cytometry as a diagnostic aid in the management of soft-tissue tumors. J Bone Joint Surg 1988;70A:751-9.
17. Fukunaga M, Shimoda T, Nikaido T, Ushigome S, Ishikawa E. Soft tissue vascular tumors: a flow cytometric DNA analysis. Cancer 1993;71:2233-41.
18. Zalupski M, Ryan JR, Ensley JF, Maciorowski Z, Pietraszkiewicz H, Hussein ME, et al. Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasms. Cytometry 1993;14:922-30.
19. Oshiro Y, Fukuda T, Tsuneyoshi M. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis: a comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry and p53. Am J Surg Pathol 1994;18:712-9.
20. Agarwal V, Greenebaum E, Wersto R, Koss LG. DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome. Arch Pathol Lab Med 1991;115:558-62.
21. Mandahl N, Baldetorp B, Ferno M, Akerman M, Rydholm A, Heim S, et al. Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumors. Int J Cancer 1993;53:358-64.
22. Mandahl N. Lipoma cytogenetics. In: Bullerdiek J, Bartnitzke S. Chromosome 12 aberrations in human solid tumors: cytogenetics and molecular genetics. Berlin, Heidelberg: Springer-Verlag, 1994:26-38.
23. Van Den Berg E, Van Oven MW, De Jong B, Dam A, Wiersema J, Dijkuizen T, et al. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Lab Invest 1994;70:307-13.
24. Xiang J, Spanier SS, Benson NA, Braylan RC. Flow cytometric analysis of DNA in bone and soft-tissue tumors using nuclear suspensions. Cancer 1987;59:1951-8.
25. El-Naggar AK, Ayala AG, Abdul-Karim FW, McLemore D, Ballance WW, Garnsey L, et al. Synovial sarcoma: a DNA flow cytometric study. Cancer 1990;65:2295-300.
26. Schmidt RA, Conrad EU III, Collins C, Rabinovitch P, Finney A. Measurement and prediction of the short-term response of soft tissue sarcomas to chemotherapy. Cancer 1993;72:2593-601.
27. Gustafson P, Fernö M, Akerman M, Baldetorp B, Willén H, Killander D, Rydholm A. Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients. Br J Cancer 1997;75:94-100.
28. Becker RL, Venzon D, Lack EE, Mikel UV, Weiss SW, O'Leary TJ. Cytometry and morphometry of malignant fibrous histiocytoma of the extremities: prediction of metastasis and mortality. Am J Surg Pathol 1991;15:957-64.
29. Huuhtanen RL, Blomqvist CP, Wiklund TA, Virolainen MJ, Inkeri Elomaa A, Yi Pan, et al. S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome. Cancer 1996;77:1815-22.
30. Ordonez NG, El-Naggar AK, Ro JY, Silva EG, Mackay B. Intraabdominal desmoplastic small cell tumor: a light microscopic, immunocytochemical, ultrastructural, and flow cytometric study. Hum Pathol 1993;24:850-65.
31. Radio SJ, Woolridge TN, Linder J. Flow cytometric DNA analysis of malignant fibrous histiocytoma and related fibrohistiocytic tumors. Hum Pathol 1988;19:74-7.
32. Alvegard TA, Berg NO, Baldetorp B, Ferno M, Killander D, Ranstam J, et al. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol 1990;8:538-47.
33. Le Doussal V, Coindre JM, Leroux A, Hacene K, Terrier P, Bui BN, et al. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer 1996;77:1823-30.
34. Pezzi ME, Rawling MS, Esgro JJ, Pollock RE, Romsdahl MM. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 1992;69:2098-103.
35. Rooser BO, Willén H, Gustafson P, Alvegard TA, Rydholm A. Malignant fibrous histiocytoma of soft tissue: a population-based epidemiologic and prognostic study of 137 patients. Cancer 1991;67:499-505.
36. Nilbert M, Rydholm A, Willén H, Mitelman F, Mandahl N. MDM2 gene correlates with ring chromosomes in soft tissue tumors. Genes Chromosomes Cancer 1994;9:261-5.
37. Turc-Carel C, Pédeutour F, Durieux E. Characteristic chromosome abnormalities and karyotypic profiles in soft tissue tumors. Harms D, Schmidt D, editors. Berlin: Springer-Verlag, 1995.
38. Gustafson P, Rydholm A, Willén H, Baldetorp B, Fernö M, Akerman M. Liposarcoma: a population-based epidemiologic and prognostic study of features of 43 patients, including tumor DNA content. Int J Cancer 1993;55:541-6.
39. Pastel-Levy C, Bell DA, Rosenberg AE, Preffer F, Colvin RB, Flotte TJ. DNA flow cytometry of epithelioid sarcoma. Cancer 1992;70:2823-6.
40. El-Naggar AK, Ordonez NG, Sara A, McLemore D, Batsakis JG. Clear cell sarcomas and metastatic soft tissue melanomas: a flow cytometric comparison and prognostic implications. Cancer 1991;67:2173-9.
41. El-Naggar AK, Garcia GM. Epithelioid sarcoma: flow cytometric study of DNA content and regional DNA heterogeneity. Cancer 1992;69:1721-8.
42. Gustafson P, Willén H, Baldetorp B, Fernö M, Akerman M, Rydholm A. Soft tissue leiomyosarcoma: a population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer 1992;70:114-9.
43. Bauer HC, Kreicsberg A, Tribukait B. DNA content prognostic in soft tissue sarcoma: 102 patients followed for 1-10 years. Acta Orthop Scand 1991;62:187-94.